5000 ORAL Long-term Outcome of HER2-positive (HER2+) Metastatic Breast Cancer (MBC) Patients (pts) Achieving Durable Complete Remission (DCR) After Trastuzumab (T)-containing Chemotherapy (CT)

2011 ◽  
Vol 47 ◽  
pp. S329-S330 ◽  
Author(s):  
G. Gullo ◽  
M. Zuradelli ◽  
F. Kelleher ◽  
F. Sclafani ◽  
N. O' Donovan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Complete Remission ◽  
Metastatic Breast ◽  
Her2 Positive ◽  
Term Outcome ◽  
Long Term Outcome

Systematic review of early and long-term outcome of liver resection for metastatic breast cancer: Is there a survival benefit?

The Breast ◽  
2017 ◽  
Vol 32 ◽  
pp. 162-172 ◽  
Author(s):  
Tae Gon Yoo ◽  
Isaac Cranshaw ◽  
Reuben Broom ◽  
Sanjay Pandanaboyana ◽  
Adam Bartlett
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Metastatic Breast Cancer ◽  
Liver Resection ◽  
Survival Benefit ◽  
Metastatic Breast ◽  
Term Outcome ◽  
Long Term Outcome

The long term outcome of clinical trial-based treatment comparing standard treatment for metastatic breast cancer.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 11106-11106
Author(s):  
Gun Min Kim ◽  
Joohyuk Sohn ◽  
Seho Park ◽  
Hyung Seok Park ◽  
Seung Il Kim
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Standard Treatment ◽  
Metastatic Breast ◽  
Term Outcome ◽  
Long Term Outcome
Sign in / Sign up

Export Citation Format

Share Document